DBV Technologies S.A. (DBVTF)
OTC Markets
Key stats Fiscal year 2025
Income statement
- Revenue
- 5,636,000 35.8%
- Net income
- -146,947,000
- Operating income
- -147,056,000
- Earnings per share
- -1.05
- R&D expense
- 116,682,000
Growth and profitability
- Operating margin
- -2,609.23
- Net margin
- -2,607.29
- Return on equity
- -87.07
- Return on assets
- -62.87
- Free cash flow margin
- -2,159.56
Balance sheet
- Total assets
- 233,718,000
- Total liabilities
- 64,948,000
- Shareholders' equity
- 168,770,000
- Cash and equivalents
- 194,167,000
- Current ratio
- 3.67
Cash flow and ratios
- Operating cash flow
- -121,181,000
- Free cash flow
- -121,713,000
Shareholder returns
- Shares outstanding
- 314,388,807
- Book value per share
- 0.54
Company information
- Headquarters
- Chatillon
- Exchange
- OTC Markets
- Fiscal year end
- 12-31
- Industry (SEC)
- Biological Products, (no Diagnostic Substances)
Fiscal year end: · Source: SEC EDGAR
DBV Technologies S.A. trades on OTC Markets under the ticker symbol DBVTF. This page brings together its price chart, company profile, key financial figures and technical indicators.